Report

Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus

+ See all authors and affiliations

Science  02 Sep 2016:
Vol. 353, Issue 6303, pp. 1045-1049
DOI: 10.1126/science.aag0491

You are currently viewing the abstract.

View Full Text

Abstract

HIV-1–specific broadly neutralizing antibodies (bNAbs) can protect rhesus monkeys against simian-human immunodeficiency virus (SHIV) challenge. However, the site of antibody interception of virus and the mechanism of antibody-mediated protection remain unclear. We administered a fully protective dose of the bNAb PGT121 to rhesus monkeys and challenged them intravaginally with SHIV-SF162P3. In PGT121-treated animals, we detected low levels of viral RNA and viral DNA in distal tissues for seven days following challenge. Viral RNA–positive tissues showed transcriptomic changes indicative of innate immune activation, and cells from these tissues initiated infection after adoptive transfer into naïve hosts. These data demonstrate that bNAb-mediated protection against a mucosal virus challenge can involve clearance of infectious virus in distal tissues.

View Full Text

Related Content